Assessment of the efficacy and safety of combination therapy of fluconazole 1% and urea 40% comparing with fluconazole 1% alone in the treatment of onychomycosis
Phase 3
- Conditions
- onychomycosis.Onychomycosis
- Registration Number
- IRCT138705301059N1
- Lead Sponsor
- Pasteur Institute of Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Presence of at least 25% involvement of the target nail, at least 2 mm of healthy nail from the nail fold to the proximal Dermatophyte onychomycosis border. Exclusion criteria: Non-dermatophytic onychomycosis, hypersensitivity to Azole derivatives, unwilling to sign informed consent, receiving systemic anti-fungal treatment or any investigational drug during three month prior to study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onychomycosis treatment. Timepoint: One month before intervention,and at months 2, 4, and 6 after intervention. Method of measurement: Laboratory Examination.
- Secondary Outcome Measures
Name Time Method